Popular drug used to treat epilepsy, bipolar disorder recalled nationwide

Bionpharma Inc. has initiated a nationwide recall of Divalproex Sodium delayed-release tablets. These tablets, widely used for the treatment of epilepsy and bipolar disorder, are under recall due to a manufacturing error involving cross-contamination. Reports indicate that foreign tablets and capsules were discovered within the product packaging.

The recall impacts 500-mg tablets sold in 500-tablet bottles. Patients who have been prescribed this medication should check their pill bottles and consult with their pharmacy or healthcare provider immediately to determine if their supply is part of the affected batch.

While the company has not provided a specific comment on the error, the recall was documented in a recent Food and Drug Administration enforcement report. Safety protocols are in place to manage the distribution of medications, and this voluntary action follows standard procedures to prevent patient exposure to contaminated products. Please contact your local pharmacy to verify your prescription details and receive guidance on safe disposal or replacement.